Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects

C. E. Shepherd; O. Piguet; G. A. Broe; H. Creasey; L. M. Waite; W. S. Brooks; J. J. Kril

doi:10.1016/j.jneuroim.2003.11.007

Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects

C. E. Shepherd^*, O. Piguet, G. A. Broe, H. Creasey, L. M. Waite, W. S. Brooks, J. J. Kril

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

HLA genotype and anti-inflammatory drug use have independently been associated with a lower risk of Alzheimer's disease (AD). We recently reported a negative association between aspirin use and AD. To investigate this further, we performed a cross-sectional study to investigate cognitive performance in 151 non-demented individuals in relation to HLA-DRB1 genotype and aspirin use. Aspirin and HLA-DRB1*01 were positive predictors of performance on logical memory (aspirin, p=0.04) and verbal fluency tests (HLA-DRB1*01, p=0.018), respectively. HLA-DRB1*05 had a negative impact on the Boston naming test (p=0.002). Our results suggest that aspirin use and inflammatory genotype may influence cognition in non-demented subjects.

Original language	English
Pages (from-to)	178-182
Number of pages	5
Journal	Journal of Neuroimmunology
Volume	148
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2003.11.007
Publication status	Published - Mar 2004
Externally published	Yes

Keywords

Anti-inflammatory
Cognition
Human leukocyte antigen

Access to Document

10.1016/j.jneuroim.2003.11.007

Cite this

@article{ffa0403d18924b7c9bb1cd2bcd709156,

title = "Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects",

abstract = "HLA genotype and anti-inflammatory drug use have independently been associated with a lower risk of Alzheimer's disease (AD). We recently reported a negative association between aspirin use and AD. To investigate this further, we performed a cross-sectional study to investigate cognitive performance in 151 non-demented individuals in relation to HLA-DRB1 genotype and aspirin use. Aspirin and HLA-DRB1*01 were positive predictors of performance on logical memory (aspirin, p=0.04) and verbal fluency tests (HLA-DRB1*01, p=0.018), respectively. HLA-DRB1*05 had a negative impact on the Boston naming test (p=0.002). Our results suggest that aspirin use and inflammatory genotype may influence cognition in non-demented subjects.",

keywords = "Anti-inflammatory, Cognition, Human leukocyte antigen",

author = "Shepherd, \{C. E.\} and O. Piguet and Broe, \{G. A.\} and H. Creasey and Waite, \{L. M.\} and Brooks, \{W. S.\} and Kril, \{J. J.\}",

year = "2004",

month = mar,

doi = "10.1016/j.jneuroim.2003.11.007",

language = "English",

volume = "148",

pages = "178--182",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects

AU - Shepherd, C. E.

AU - Piguet, O.

AU - Broe, G. A.

AU - Creasey, H.

AU - Waite, L. M.

AU - Brooks, W. S.

AU - Kril, J. J.

PY - 2004/3

Y1 - 2004/3

N2 - HLA genotype and anti-inflammatory drug use have independently been associated with a lower risk of Alzheimer's disease (AD). We recently reported a negative association between aspirin use and AD. To investigate this further, we performed a cross-sectional study to investigate cognitive performance in 151 non-demented individuals in relation to HLA-DRB1 genotype and aspirin use. Aspirin and HLA-DRB1*01 were positive predictors of performance on logical memory (aspirin, p=0.04) and verbal fluency tests (HLA-DRB1*01, p=0.018), respectively. HLA-DRB1*05 had a negative impact on the Boston naming test (p=0.002). Our results suggest that aspirin use and inflammatory genotype may influence cognition in non-demented subjects.

AB - HLA genotype and anti-inflammatory drug use have independently been associated with a lower risk of Alzheimer's disease (AD). We recently reported a negative association between aspirin use and AD. To investigate this further, we performed a cross-sectional study to investigate cognitive performance in 151 non-demented individuals in relation to HLA-DRB1 genotype and aspirin use. Aspirin and HLA-DRB1*01 were positive predictors of performance on logical memory (aspirin, p=0.04) and verbal fluency tests (HLA-DRB1*01, p=0.018), respectively. HLA-DRB1*05 had a negative impact on the Boston naming test (p=0.002). Our results suggest that aspirin use and inflammatory genotype may influence cognition in non-demented subjects.

KW - Anti-inflammatory

KW - Cognition

KW - Human leukocyte antigen

UR - https://www.scopus.com/pages/publications/1242340269

U2 - 10.1016/j.jneuroim.2003.11.007

DO - 10.1016/j.jneuroim.2003.11.007

M3 - Article

C2 - 14975599

AN - SCOPUS:1242340269

SN - 0165-5728

VL - 148

SP - 178

EP - 182

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this